Loading…
Lobbying Spend
—
Filings
51
Firms Hired
1
Active Period
1999–2017
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Restoring the Patient's Voice Act of 2017
2017 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2017 (H.R. 2999) Biosimilars legislation & FDA guidance NIH-funding for NIDDK Restoring the Patient's Voice Act of 2017 (H.R. 2077) Healthcare Reform
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2077
Patients' Access to Treatments Act of 2017
2017 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2017 (H.R. 2999) Biosimilars legislation & FDA guidance NIH-funding for NIDDK Restoring the Patient's Voice Act of 2017 (H.R. 2077) Healthcare Reform
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2999
Restoring the Patient's Voice Act of 2017
2017 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2017 (H.R. 2999) Biosimilars legislation & FDA guidance NIH-funding for NIDDK Restoring the Patient's Voice Act of 2017 (H.R. 2077) Healthcare Reform
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2077
Patients' Access to Treatments Act of 2017
2017 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2017 (H.R. 2999) Biosimilars legislation & FDA guidance NIH-funding for NIDDK Restoring the Patient's Voice Act of 2017 (H.R. 2077) Healthcare Reform
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2999
Patients' Access to Treatments Act of 2015
2017 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2015 (H.R. 1600) Biosimilars legislation & FDA guidance NIH-funding for NIDDK
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1600
Patients' Access to Treatments Act of 2015
2016 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2015 (H.R. 1600) Biosimilars legislation & FDA guidance NIH-funding for NIDDK
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1600
Patients' Access to Treatments Act of 2015
2016 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2015 (H.R. 1600) Biosimilars legislation & FDA guidance NIH-funding for NIDDK
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1600
Patients' Access to Treatments Act of 2015
2016 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2015 (H.R. 1600) Biosimilars legislation & FDA guidance NIH-funding for NIDDK
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1600
Patients' Access to Treatments Act of 2015
2016 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2015 (H.R. 1600) Biosimilars legislation & FDA guidance NIH-funding for NIDDK
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1600
Patients' Access to Treatments Act of 2015
2015 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2015 (H.R. 1600) Biosimilars legislation & FDA guidance NIH-funding for NIDDK
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1600
Patients' Access to Treatments Act of 2015
2015 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
IBD Congressional Caucus CDC funding-IBD Epidemiology program Department of Defense, Congressionally Directed Medical Research Program, Peer Reviewed Medical Research Program-inclusion of IBD as a condition for study Patients Access to Treatments Act of 2015 (H.R. 1600) Biosimilars legislation & FDA guidance NIH-funding for NIDDK
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1600
Inflammatory Bowel Disease Research and Awareness Act
2010 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Inflammatory Bowel Disease Research Programs at NIH and CDC HR 2275 & S 981: Inflammatory Bowel Disease Research and Awareness Act H Res 1444: Recognizing the 60th Anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases
Client expense: — · Firm income: $10,000
Matched citations: HR 2275
Recognizing the 60th anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases.
2010 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Inflammatory Bowel Disease Research Programs at NIH and CDC HR 2275 & S 981: Inflammatory Bowel Disease Research and Awareness Act H Res 1444: Recognizing the 60th Anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases
Client expense: — · Firm income: $10,000
Matched citations: H Res 1444
Inflammatory Bowel Disease Research and Awareness Act
2010 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Inflammatory Bowel Disease Research Programs at NIH and CDC HR 2275 & S 981: Inflammatory Bowel Disease Research and Awareness Act H Res 1444: Recognizing the 60th Anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases
Client expense: — · Firm income: $10,000
Matched citations: S 981
Inflammatory Bowel Disease Research and Awareness Act
2010 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Inflammatory Bowel Disease Research Programs at NIH and CDC HR 2275 & S 981: Inflammatory Bowel Disease Research and Awareness Act H Res 1444: Recognizing the 60th Anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases
Client expense: — · Firm income: $10,000
Matched citations: HR 2275
Recognizing the 60th anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases.
2010 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Inflammatory Bowel Disease Research Programs at NIH and CDC HR 2275 & S 981: Inflammatory Bowel Disease Research and Awareness Act H Res 1444: Recognizing the 60th Anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases
Client expense: — · Firm income: $10,000
Matched citations: H Res 1444
Inflammatory Bowel Disease Research and Awareness Act
2010 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Inflammatory Bowel Disease Research Programs at NIH and CDC HR 2275 & S 981: Inflammatory Bowel Disease Research and Awareness Act H Res 1444: Recognizing the 60th Anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases
Client expense: — · Firm income: $10,000
Matched citations: S 981
Inflammatory Bowel Disease Research and Awareness Act
2010 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Inflammatory Bowel Disease Research Programs at NIH and CDC HR 2275 & S 981: Inflammatory Bowel Disease Research and Awareness Act H Res 1444: Recognizing the 60th Anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases
Client expense: — · Firm income: $10,000
Matched citations: HR 2275
Recognizing the 60th anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases.
2010 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Inflammatory Bowel Disease Research Programs at NIH and CDC HR 2275 & S 981: Inflammatory Bowel Disease Research and Awareness Act H Res 1444: Recognizing the 60th Anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases
Client expense: — · Firm income: $10,000
Matched citations: H Res 1444
Inflammatory Bowel Disease Research and Awareness Act
2010 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Inflammatory Bowel Disease Research Programs at NIH and CDC HR 2275 & S 981: Inflammatory Bowel Disease Research and Awareness Act H Res 1444: Recognizing the 60th Anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases
Client expense: — · Firm income: $10,000
Matched citations: S 981
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
H.R. 3590: Patient Protection and Affordable Care Act (pre-existing condition exclusion elimination, lifetime and annual benefit cap elimination, Cures Acceleration Network establishment, coverage of clinical trials) H.R. 4872: Reconciliation Act of 2010 (lifetime and annual cap elimination) Inflammatory Bowel Disease Research Programs at NIH and CDC H.R. 2275 & S. 981: Inflammatory Bowel Disease Research and Awareness Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3590
Inflammatory Bowel Disease Research and Awareness Act
2010 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
H.R. 3590: Patient Protection and Affordable Care Act (pre-existing condition exclusion elimination, lifetime and annual benefit cap elimination, Cures Acceleration Network establishment, coverage of clinical trials) H.R. 4872: Reconciliation Act of 2010 (lifetime and annual cap elimination) Inflammatory Bowel Disease Research Programs at NIH and CDC H.R. 2275 & S. 981: Inflammatory Bowel Disease Research and Awareness Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2275
Inflammatory Bowel Disease Research and Awareness Act
2010 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
H.R. 3590: Patient Protection and Affordable Care Act (pre-existing condition exclusion elimination, lifetime and annual benefit cap elimination, Cures Acceleration Network establishment, coverage of clinical trials) H.R. 4872: Reconciliation Act of 2010 (lifetime and annual cap elimination) Inflammatory Bowel Disease Research Programs at NIH and CDC H.R. 2275 & S. 981: Inflammatory Bowel Disease Research and Awareness Act
Client expense: — · Firm income: $10,000
Matched citations: S. 981
Early Treatment for HIV Act of 2007
2009 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
HR 3293, House and Senate FY10 Labor-HHS Appropriations Bills (Biomedical Research & Disease Prevention Programs) HR 3326, House and Senate FY10 DoD Appropriations Bills (Peer Reviewed and Medical Research Programs) HR 3288, Consolidated Appropriations Act of 2010
Client expense: — · Firm income: $10,000
Matched citations: HR 3326
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
HR 3200: America's Affordable Health Care Choices Act S 1679: Affordable Health Choices Act HR 3590: Patient Protection and Affordable Care Act HR 3962: Affordable Health Care for America Act HR 1558 & S 623: Pre-existing Condition Patient Protection Act HR 1708 & S 700: Ending the Medicare Disability Waiting Period Act of 2009 Inflammatory Bowel Disease Research Programs at NIH and CDC HR 1085 & S 442: Health Insurance Coverage Protection Act HR 2275 & S 981: Inflammatory Bowel Disease Research and Awareness Act
Client expense: — · Firm income: $10,000
Matched citations: HR 3590
Source: Senate LDA